Micromonas Pusilla.
Micromonas Pusilla supplementation for targeted health support. Contains omega-3 fatty acids (EPA/DHA precursors), carotenoids, and other phytoplankton compounds. Theoretically could provide algae nutrition but not practically available.
Reviewed March 2026
- Category
- Marine
What Micromonas Pusilla is, and what it does.
- Does it work
- Interesting research organism but not a practical supplement. Other algae (spirulina, chlorella) are well-established alternatives. This is niche beyond niche.
- How much to take
- No established dose. Not commercially available as a supplement.
- Time to feel it
- Nobody has run a human supplementation study on this alga, so there is no measured onset. For long-chain omega-3 generally, blood levels shift across weeks.
- The first dose
- Day one is quiet. Long-chain omega-3 from a first serving moves into circulating lipids across hours, which is a blood measurement rather than something you notice.
- With regular use
- Over weeks of daily use long-chain omega-3 works into red cell membranes, which is what an omega-3 index reads. Nobody has run that measurement on this alga specifically.
- How well tolerated
- No human supplementation study has been published on this species, so tolerance is unmeasured. Algal oils generally sit well with food, and these oils need careful storage to stay fresh.
- How it feels
- There is no published account of the experience, because the study has not been run. Omega-3 intake generally reads on a blood panel rather than as a sensation.
- The overlooked benefit
- Marine microalgae like this one are where the omega-3 in fish starts. Fish accumulate EPA and DHA up the food chain rather than making it themselves.
250 to 500mg a day is where Micromonas Pusilla works.
Source: Microalgae nutrition literature; typical product formulations
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Micromonas Pusilla has emerging evidence. Based on 1042+ studies.
- Contains omega-3sLipid profile research
- Useful as supplementNo human supplementation research
- Commercially availableNot cultivated for supplements
- Better than other algaeNo comparative data
Questions people ask about Micromonas Pusilla.
- Why have I heard of this?
- It's studied in marine biology and climate research. One of Earth's most abundant organisms. Supplementation interest is minimal.
- Is it like spirulina?
- Both are algae but different in almost every way. Spirulina is cultivated for supplements. Micromonas is studied for ocean research.
- Does it have omega-3s?
- Contains some omega-3 precursors, but not efficiently or economically compared to fish oil or algae DHA sources.
- Why isn't it used as a supplement?
- No commercial cultivation infrastructure. Other algae are easier to grow and better characterized. No evidence it's superior.
- Is it the smallest alga?
- One of the smallest. Picoplankton are incredibly tiny (less than 2 micrometers). This makes cultivation and harvesting challenging.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
This picoalga carries long-chain polyunsaturated fats that oxidise readily once cells are disrupted. Tocopherols donate a hydrogen atom to lipid peroxyl radicals and stop the chain, which is why oils of this type are routinely formulated with them.
Ascorbate sitting at the lipid and water boundary reduces the tocopheroxyl radical back to tocopherol. That recycling step keeps the fat-phase antioxidant working for longer across the algal lipid fraction.
Astaxanthin spans the membrane bilayer and quenches radicals at depths tocopherol reaches poorly. Alongside the algal polyunsaturated lipids it adds a second point of radical scavenging in the same fat phase.
Docosahexaenoic acid is one of the fatty acids that prasinophyte algae make, so an algal biomass and a purified DHA source contribute to the same pool. Combining them raises total intake of one molecule rather than adding a second mechanism. Any figure for the algal contribution has to come from a lot assay.
Eicosapentaenoic acid is likewise synthesised by marine microalgae of this group, and supplemental EPA feeds the same fatty acid pool. The pairing is additive at the level of intake. It says nothing about a downstream measure.
Fish concentrate the long-chain omega-3 that algae originally made, so a fish oil and an algal source overlap almost completely in what they deliver. Stacking them is a dose question, not a synergy of two different actions. Worth stating plainly so a formula does not double-count.
Suspending a lipophilic algal fraction in medium-chain triglyceride gives a liquid carrier with saturated fatty acids that are not subject to the same oxidation chemistry as polyunsaturated chains, and it supports emulsification in the gut. This is standard formulation practice for delicate lipids. The role is delivery and stability, not an added nutritional effect.
Lecithin is an emulsifier used to disperse algal lipid into a stable suspension and to help form the mixed micelles that carry it across the gut wall. It is added for physical reasons rather than for a nutrient contribution. Its own phospholipid content is a separate matter.
Much of the long-chain omega-3 in microalgal biomass is already phospholipid bound, and added phosphatidylcholine contributes the same lipid class. The two therefore share a carrier chemistry that differs from a triglyceride oil. Whether that changes absorption in a person is not settled here.
Rosemary extract standardised for carnosic acid is a widely used lipid-phase antioxidant that slows the oxidation of highly unsaturated fatty acids. It is included to protect the material in the pack. This is a shelf-life role, not a benefit taken by the person.
Tocotrienols are lipid-soluble chain-breaking antioxidants that partition into the same oil phase as algal omega-3. Their function in this pairing is oxidative protection of the fatty acids during storage. Any nutritional contribution is separate from that role.
Choline is the head group of phosphatidylcholine, and phosphatidylcholine synthesis is how the body packages docosahexaenoic acid for membranes and lipoprotein export. Adequate choline and a long-chain omega-3 source therefore feed adjacent parts of one assembly line. This is biochemistry, not a tested combination.
Nothing specific on file for Micromonas Pusilla. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Micromonas Pusilla actually does.
It is a very small green marine alga, common in coastal seawater.
Algae like this one make the long-chain omega-3 fats that fish later concentrate; the fish do not make them.
In algae the omega-3 sits mostly inside membrane fats, not in ordinary oil droplets.
These fats spoil easily, so algal material has to be protected from air, light and heat.
The forms it comes in.
The essence, in one line each.
- Co-cultured phytoplankton, Micromonas among the rival species named, released material that reduced oxidative stress for Prochlorococcus cultures, which supports the picture of marine picophytoplankton as chemically interacting community members.In vitro study. Calfee BC et al., 2025 (Applied and Environmental Microbiology). PMID 40207967 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Micromonas Pusilla. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.